Glimepiride and Metformin hydrochloride tablets | GLIMITERIS M1
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Glimepiride & Metformin Hydrochloride Prolonged Release
Rs 75.47
MRP Rs 107.81
(30% OFF)
Includes all taxes
Package SIZE
( For 15 Tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
GLIMITERIS M1 is a fixed-dose combination medicine used in the management of Type 2 Diabetes Mellitus, designed for patients whose blood sugar is not adequately controlled on Metformin alone, or who need a comprehensive dual-mechanism approach to glycemic control. It brings together two well-established, complementary anti-diabetic agents:
Glimepiride, a sulfonylurea, works by stimulating the beta cells of the pancreas to release more insulin into the bloodstream, helping the body process circulating glucose more effectively, particularly around mealtimes.
Metformin Hydrochloride (Prolonged Release), a biguanide, works through a different mechanism — reducing the amount of glucose the liver releases into the bloodstream and improving the sensitivity of body tissues to insulin, allowing existing insulin to work more efficiently. The prolonged-release formulation allows the medicine to release gradually over time, providing steadier drug levels throughout the day, generally improving gastrointestinal tolerability, and often allowing for convenient once-daily dosing compared to immediate-release Metformin.
By combining a medicine that increases insulin availability (Glimepiride) with one that improves how effectively the body uses insulin (Metformin PR), GLIMITERIS M1 addresses blood sugar control from two complementary angles, often achieving better glycemic control than either medicine alone, while offering the added convenience and tolerability benefits of the prolonged-release format.
Product Information
| Attribute | Details |
|---|---|
| Brand Name | GLIMITERIS M1 |
| Composition | Glimepiride + Metformin Hydrochloride (Prolonged Release) |
| Therapeutic Class | Anti-diabetic — Sulfonylurea + Biguanide (Fixed-Dose Combination) |
| Manufacturer/Marketer | Steris Healthcare Pvt. Ltd. |
| Product Form | Prolonged-Release (PR) Tablet |
| Pack Size | 15 Tablets |
| Prescription Status | Schedule H — Prescription drug only |
| Price (MRP) | ₹[Placeholder — insert price] |
| SKU / Batch Ref. | [Placeholder — insert SKU] |
| Storage | Store below 25°C, in a cool, dry place, protected from light and moisture |
Why GLIMITERIS M1 Is Important
Type 2 diabetes is a progressive metabolic condition, and for many patients, blood sugar control with Metformin alone becomes insufficient over time as insulin resistance or reduced pancreatic function progresses. Consistently high blood sugar levels, if left inadequately managed, substantially raise the risk of serious long-term complications, including damage to the eyes, kidneys, nerves, and cardiovascular system.
GLIMITERIS M1 plays an important role because it:
- Offers dual-mechanism blood sugar control, combining increased insulin release with improved insulin sensitivity
- Provides a practical treatment intensification option for patients whose diabetes is not adequately controlled on Metformin alone
- The prolonged-release Metformin component supports steadier drug levels, better gastrointestinal tolerability, and convenient once-daily dosing
- Simplifies treatment by combining two medicines into one tablet, reducing pill burden and supporting better adherence
- Supports better long-term HbA1c control, directly linked to reduced risk of diabetes-related complications
- Offers a well-established, extensively used combination in diabetes management, backed by long clinical experience
Because this combination involves two distinct drug classes, each with its own considerations around hypoglycemia risk and kidney function, it requires careful physician oversight to ensure it is appropriately matched to each patient's individual diabetes profile.
Key Benefits
- Dual-action mechanism — combines increased insulin secretion with improved insulin sensitivity for effective blood sugar control
- Prolonged-release Metformin component supports steadier drug levels, better tolerability, and convenient once-daily dosing
- Reduces pill burden by combining two anti-diabetic medicines into a single tablet
- Supports better long-term HbA1c and glycemic control, reducing risk of diabetes-related complications
- Useful intensification option for patients not adequately controlled on Metformin alone
- Well-established combination with a long track record of clinical use in Type 2 diabetes management
- Backed by WHO-GMP certified manufacturing, ensuring consistent tablet quality and dosing accuracy
Precautions
- Should be used only under medical supervision, with regular monitoring of blood glucose, HbA1c, and kidney function
- Caution advised in patients with kidney impairment, as Metformin use requires dose adjustment or avoidance based on kidney function levels
- Risk of hypoglycemia (low blood sugar) exists, mainly due to the Glimepiride component — patients should be aware of symptoms (sweating, shakiness, confusion, dizziness) and how to respond
- Should be used cautiously in patients with liver disease, heart failure, or conditions predisposing to lactic acidosis (a rare but serious risk associated with Metformin)
- Alcohol should be avoided or limited, as it can increase the risk of hypoglycemia and lactic acidosis
- Temporary discontinuation may be required before procedures involving contrast dye (imaging scans) or major surgery — inform all treating doctors that this medicine is being taken
- Not recommended during pregnancy or breastfeeding unless specifically advised by a physician
- Elderly patients may be more sensitive to hypoglycemia and should be monitored closely
- Meals should not be skipped while on this medicine, to reduce the risk of low blood sugar episodes
- Inform the doctor of all other medications, as several drug classes can interact with components of this combination
Side Effects
- Gastrointestinal discomfort — nausea, bloating, or diarrhea (particularly with the Metformin component, often improving over time)
- Hypoglycemia (low blood sugar) — more likely if meals are skipped or delayed
- Metallic taste in the mouth
- Loss of appetite
- Headache
- Dizziness
- Rarely: lactic acidosis (a serious condition requiring emergency care — symptoms include severe muscle pain, difficulty breathing, unusual tiredness, and stomach discomfort)
- Rarely: allergic skin reactions
Frequently Asked Questions
1. Where can I buy Glimepiride and Metformin Hydrochloride Tablets online?
Glimepiride and Metformin Hydrochloride Tablets can be purchased through licensed online pharmacies and authorized pharmaceutical suppliers in India. Check the strength, formulation, manufacturer, pack size, and prescription requirements before ordering.
2. What is the price of Glimepiride and Metformin Hydrochloride Tablets?
The price may vary depending on the brand, strength, formulation, manufacturer, pack size, and seller. Check the current product listing or contact an authorized pharmaceutical supplier for the latest price.
3. Can I order Glimepiride and Metformin Hydrochloride Tablets online?
Yes, these tablets may be ordered online through licensed pharmacies or authorized pharmaceutical suppliers, subject to availability and prescription requirements. Always purchase medicines from a trusted and verified source.
4. Is Glimepiride and Metformin Hydrochloride Tablets available from Steris Healthcare?
Availability from Steris Healthcare depends on the specific brand, strength, formulation, pack size, and current stock. For products such as GLIMITERIS M2, contact Steris Healthcare or check the relevant product listing for current availability and ordering details.
5. What are Glimepiride and Metformin Hydrochloride Tablets used for?
Glimepiride and Metformin Hydrochloride Tablets are antidiabetic medicines used along with diet and exercise to help control blood glucose levels in adults with type 2 diabetes mellitus. The combination works through different mechanisms to improve blood sugar control.
6. What is the composition of Glimepiride and Metformin Hydrochloride Tablets?
The composition depends on the specific brand and strength. GLIMITERIS M2 contains Glimepiride 2 mg and Metformin Hydrochloride 500 mg Prolonged Release per tablet.
7. Is a prescription required for Glimepiride and Metformin Hydrochloride Tablets?
Yes, these are prescription medicines and should be used under the guidance of a qualified healthcare professional. The doctor determines the appropriate strength and dosage according to the patient's needs.
8. How should Glimepiride and Metformin Hydrochloride Tablets be taken?
Take the tablets exactly as prescribed by your doctor. Prolonged-release tablets should generally be swallowed whole and should not be crushed or chewed unless specifically instructed. Follow the prescribed dose and timing, and do not change or stop treatment without medical advice.
9. What should I know before buying Glimepiride and Metformin Hydrochloride Tablets?
Before buying, verify the brand name, strength, composition, formulation, manufacturer, pack size, batch number, expiry date, and prescription requirements. Inform your healthcare professional about other medicines you take and any kidney, liver, or other relevant medical conditions.
10. How can I order Glimepiride and Metformin Hydrochloride Tablets online?
To order online, select the required brand and strength from a licensed pharmacy or authorized pharmaceutical supplier. Verify the product information and prescription requirements, provide a valid prescription when required, and complete the available ordering and payment process.